scholarly journals Factors Affecting Long Term Survival for Metastatic Gastric Cancer Treated with Chemotherapy

Author(s):  
Seong Kyeong Lim ◽  
Kyoungwon Jung ◽  
Moo In Park ◽  
Jae Hyun Kim ◽  
Sung Eun Kim ◽  
...  
2017 ◽  
Vol 6 (2) ◽  
pp. 163-166 ◽  
Author(s):  
Takahiro Einama ◽  
Hironori Abe ◽  
Shunsuke Shichi ◽  
Hiroki Matsui ◽  
Ryo Kanazawa ◽  
...  

2015 ◽  
Vol 16 (13) ◽  
pp. 5433-5438 ◽  
Author(s):  
Shigenori Kadowaki ◽  
Azusa Komori ◽  
Daisuke Takahari ◽  
Takashi Ura ◽  
Seiji Ito ◽  
...  

2021 ◽  
pp. 67-72
Author(s):  
Sung Jin Oh

Liver metastasis from gastric cancer has a very poor prognosis. Herein, we present two cases of liver metastases (synchronous and metachronous) from advanced gastric cancer. In the first case, the patient underwent radical subtotal gastrectomy. Liver metastases occurred 6 months after surgery while the patient was receiving adjuvant chemotherapy, but two hepatic tumors were successfully removed by radiofrequency ablation (RFA). In the second case, liver metastases occurred 15 months after surgery for gastric cancer. The patient also received RFA for one hepatic tumor, and other suspicious metastatic tumors were treated with systemic chemotherapy. Although these case presentations are limited for the efficacy of RFA treatment with systemic chemotherapy for hepatic metastases from gastric cancer, our findings showed long-term survival (overall survival for 108 and 67 months, respectively) of the affected patients, without recurrence. Therefore, we suggest that RFA treatment with systemic chemotherapy could be an effective alternative treatment modality for hepatic metastases from gastric cancer.


2017 ◽  
Vol 28 ◽  
pp. iii47
Author(s):  
Changming Huang ◽  
Qi-Yue Chen ◽  
Zhi-Liang Hong ◽  
Chao-Hui Zheng ◽  
Ping Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document